Chemed Corporation (CHE) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $371.95 ist Chemed Corporation (CHE) ein Healthcare-Unternehmen mit einer Bewertung von 6B. Bewertet mit 46/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 3. Feb. 2026Chemed Corporation (CHE) Gesundheitswesen & Pipeline-Uebersicht
Chemed Corporation, a leader in hospice care and plumbing services, offers a unique blend of healthcare stability and essential home services, driving consistent revenue and profitability with a diversified business model and a strong market presence in the United States.
Investmentthese
Chemed Corporation presents a notable research candidate due to its diversified business model and strong market positions in both hospice care and plumbing services. The VITAS Healthcare segment benefits from the growing demand for hospice care driven by an aging population, while Roto-Rooter provides stable revenue through essential home services. With a P/E ratio of 22.69 and a profit margin of 11.0%, Chemed demonstrates financial stability and profitability. The company's dividend yield of 0.51% offers a modest income stream. Upcoming expansion of VITAS into underserved markets and ongoing operational efficiencies in Roto-Rooter are expected to drive future growth. Investors may want to evaluate Chemed for its diversified revenue streams, stable financial performance, and growth potential in expanding markets.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market Cap of $6.34B reflects Chemed's significant presence in the healthcare and home services sectors.
- P/E ratio of 22.69 indicates investor confidence in Chemed's earnings potential.
- Profit Margin of 11.0% demonstrates effective cost management and profitability.
- Gross Margin of 32.2% highlights the company's ability to generate revenue after accounting for the cost of goods sold.
- Beta of 0.46 suggests lower volatility compared to the overall market, making it a relatively stable investment.
Wettbewerber & Vergleichsunternehmen
Staerken
- Diversified revenue streams from hospice care and plumbing services.
- Strong brand recognition and market presence in both segments.
- Established network of company-owned branches and franchisees.
- Stable demand for essential services in healthcare and home maintenance.
Schwaechen
- Exposure to regulatory changes in the healthcare industry.
- Dependence on referrals for hospice care patients.
- Potential for increased competition in both segments.
- Labor-intensive business model with high employee turnover.
Katalysatoren
- Ongoing: Aging population driving increased demand for hospice care services.
- Upcoming: Expansion of VITAS Healthcare into new geographic markets.
- Ongoing: Implementation of operational efficiencies in Roto-Rooter.
- Upcoming: Potential acquisitions of smaller hospice providers and plumbing companies.
Risiken
- Potential: Changes in government regulations affecting hospice care reimbursement.
- Potential: Economic downturn impacting demand for plumbing services.
- Ongoing: Increased competition in both the hospice care and plumbing sectors.
- Ongoing: Rising labor costs and regulatory compliance expenses.
- Potential: Negative publicity or litigation related to service quality or patient care.
Wachstumschancen
- Expansion of VITAS Healthcare Services: VITAS has the opportunity to expand its hospice care services into underserved geographic areas, particularly in rural communities and regions with limited access to specialized end-of-life care. The market for hospice care is projected to reach $40 billion by 2028, driven by the aging population and increasing awareness of the benefits of hospice. This expansion can be achieved through strategic acquisitions, partnerships with local healthcare providers, and the establishment of new VITAS facilities, enhancing market share and revenue growth.
- Technological Innovation in Roto-Rooter: Roto-Rooter can leverage technological advancements to improve service delivery and customer experience. Implementing smart plumbing solutions, such as leak detection systems and remote monitoring, can provide added value to customers and differentiate Roto-Rooter from competitors. The market for smart plumbing is expected to grow to $10 billion by 2027, driven by increasing demand for water conservation and efficient home management. Investing in these technologies can attract new customers and enhance customer retention.
- Strategic Acquisitions: Chemed can pursue strategic acquisitions in both the hospice care and plumbing services sectors to expand its market presence and service offerings. Acquiring smaller hospice providers can provide access to new geographic markets and patient populations. Similarly, acquiring regional plumbing companies can strengthen Roto-Rooter's market share and expand its service capabilities. These acquisitions can be funded through a combination of cash and debt, enhancing Chemed's long-term growth prospects.
- Enhanced Customer Service and Loyalty Programs: Implementing enhanced customer service initiatives and loyalty programs can improve customer satisfaction and retention in both VITAS and Roto-Rooter. For VITAS, this includes providing additional support services to families and caregivers, such as grief counseling and respite care. For Roto-Rooter, this includes offering discounts and priority service to repeat customers. These initiatives can increase customer loyalty and drive repeat business, contributing to revenue growth and profitability.
- Partnerships with Healthcare Providers: VITAS can form strategic partnerships with hospitals, nursing homes, and other healthcare providers to increase referrals and expand its reach. These partnerships can involve co-location of VITAS services within healthcare facilities, joint marketing initiatives, and shared electronic health records. By collaborating with other healthcare providers, VITAS can improve access to hospice care for patients and enhance its reputation as a leading provider of end-of-life care.
Chancen
- Expansion into underserved geographic markets.
- Strategic acquisitions to increase market share.
- Technological innovation to improve service delivery.
- Partnerships with healthcare providers to increase referrals.
Risiken
- Changes in government reimbursement policies for hospice care.
- Economic downturn affecting demand for plumbing services.
- Increased competition from national and regional players.
- Rising labor costs and regulatory compliance expenses.
Wettbewerbsvorteile
- Established brand reputation in both hospice care (VITAS) and plumbing services (Roto-Rooter).
- Extensive network of company-owned branches, contractors, and franchisees.
- Diversified revenue streams from healthcare and home services.
- Specialized expertise and training in both hospice care and plumbing services.
Ueber CHE
Chemed Corporation, established in 1970 and headquartered in Cincinnati, Ohio, has evolved into a diversified company operating primarily in two distinct segments: VITAS Healthcare and Roto-Rooter. VITAS Healthcare, a significant contributor to Chemed's revenue, provides hospice and palliative care services to patients facing life-limiting illnesses. These services are delivered through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers, ensuring comprehensive care and support for patients and their families. Roto-Rooter, the other key segment, offers plumbing, drain cleaning, excavation, water restoration, and other related services to both residential and commercial customers. This segment operates through a combination of company-owned branches, independent contractors, and franchisees, extending its reach across a wide geographic area. Chemed's strategic diversification allows it to tap into stable demand in both the healthcare and home services sectors, providing a resilient business model. The company's commitment to quality care and reliable service has solidified its position in the market, driving consistent financial performance.
Was das Unternehmen tut
- Provides hospice and palliative care services through VITAS Healthcare.
- Offers plumbing, drain cleaning, and excavation services through Roto-Rooter.
- Delivers end-of-life care to patients with life-limiting illnesses.
- Provides residential and commercial plumbing solutions.
- Operates through a network of physicians, nurses, and home health aides.
- Utilizes company-owned branches, contractors, and franchisees for service delivery.
- Offers water restoration services.
Geschaeftsmodell
- Generates revenue through hospice care services provided by VITAS Healthcare.
- Earns revenue from plumbing and drain cleaning services offered by Roto-Rooter.
- Utilizes a combination of company-owned operations and franchise agreements.
- Focuses on providing essential services with recurring revenue streams.
Branchenkontext
Chemed Corporation operates within the healthcare and home services industries, both experiencing steady growth. The hospice care market is expanding due to the aging population and increasing awareness of end-of-life care options. The plumbing services market benefits from ongoing demand for maintenance and repair services in residential and commercial properties. Chemed's competitors include companies like DaVita (DVA) in healthcare and others like Broadridge Financial Solutions (BRKR) in business services, though Roto-Rooter's market is more fragmented. The company's diversified approach allows it to capitalize on the strengths of both industries, mitigating risks associated with relying on a single market.
Wichtige Kunden
- Patients with life-limiting illnesses and their families (VITAS).
- Residential homeowners requiring plumbing services (Roto-Rooter).
- Commercial businesses needing plumbing and drain cleaning (Roto-Rooter).
- Healthcare facilities seeking hospice care partners (VITAS).
Finanzdaten
Chart & Info
Chemed Corporation (CHE) Aktienkurs: $371.95 (-2.07, -0.55%)
Aktuelle Nachrichten
-
Nvidia Slumps Over 4%, Wall Street's Fear Gauge Rallies: What's Moving Markets Thursday?
benzinga · 26. Feb. 2026
-
Earnings Scheduled For February 25, 2026
benzinga · 25. Feb. 2026
-
Kate Spade Outlet is selling a $239 pebbled leather wallet for just $63
TheStreet · 20. Feb. 2026
-
1 Cash-Producing Stock to Consider Right Now and 2 We Find Risky
Yahoo! Finance: CHE News · 18. Feb. 2026
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CHE.
Kursziele
Konsens-Kursziel: $475.00
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von CHE auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Wettbewerber & Vergleichsunternehmen
Aktuelle Nachrichten
Nvidia Slumps Over 4%, Wall Street's Fear Gauge Rallies: What's Moving Markets Thursday?
Earnings Scheduled For February 25, 2026
Kate Spade Outlet is selling a $239 pebbled leather wallet for just $63
1 Cash-Producing Stock to Consider Right Now and 2 We Find Risky
Haeufige Fragen zu CHE
What are the key factors to evaluate for CHE?
Chemed Corporation (CHE) currently holds an AI score of 46/100, indicating low score. The stock trades at a P/E of 20.3x, near the S&P 500 average (~20-25x). Analysts target $475.00 (+28% from $371.95). Key strength: Diversified revenue streams from hospice care and plumbing services.. Primary risk to monitor: Potential: Changes in government regulations affecting hospice care reimbursement.. This is not financial advice.
How frequently does CHE data refresh on this page?
CHE prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CHE's recent stock price performance?
Recent price movement in Chemed Corporation (CHE) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $475.00 implies 28% upside from here. Notable catalyst: Diversified revenue streams from hospice care and plumbing services.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CHE overvalued or undervalued right now?
Determining whether Chemed Corporation (CHE) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 20.3. Analysts target $475.00 (+28% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CHE?
Before investing in Chemed Corporation (CHE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding CHE to a portfolio?
Potential reasons to consider Chemed Corporation (CHE) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Diversified revenue streams from hospice care and plumbing services.. Additionally: Strong brand recognition and market presence in both segments.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of CHE?
Yes, most major brokerages offer fractional shares of Chemed Corporation (CHE) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track CHE's earnings and financial reports?
Chemed Corporation (CHE) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CHE earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Information is based on available data as of 2026-02-03.
- Future performance is subject to market conditions and company-specific factors.